LONDON, May 2 (Reuters) – Novo Nordisk has seen the price of its hugely popular weight-loss drug Wegovy and diabetes drug Ozempic fall in the United States as volumes and competition ...
, opens new tab has seen the price of its hugely popular weight-loss drug Wegovy and diabetes drug Ozempic fall in the United States as volumes and competition have increased, a senior executive ...
The prices of Novo Nordisk’s (NOV) popular GLP-1 drugs Wegovy and Ozempic reportedly fell during the first quarter due to higher volumes and increased competition, with the company expecting ...
The maker of the Ozempic and Wegovy drugs has seen its share price fall more than 5% over the past two days, erasing over $30 billion from its market value. Novo’s U.S.-listed shares fell 1.5% ...
Novo Nordisk’s American depositary receipts slipped nearly 3%, despite reporting higher quarterly sales and profits fueled by blockbuster diabetes and weight-loss drugs Ozempic and Wegovy.
LONDON, May 2 (Reuters) - Novo Nordisk has seen the price of its hugely popular weight-loss drug Wegovy and diabetes drug Ozempic fall in the United States as volumes and competition have ...
LONDON, May 2 (Reuters) – Novo Nordisk has seen the price of its hugely popular weight-loss drug Wegovy and diabetes drug Ozempic fall in the United States as volumes and competition have increased, a ...
LONDON (Reuters) - Novo Nordisk (CSE:NOVOb) has seen the price of its hugely popular weight-loss drug Wegovy and diabetes drug Ozempic fall in the United States as volumes and competition have ...